ETNB |
89bio, Inc. |
Aug 17, 2024 |
1 |
-$37K |
4 |
Aug 19, 2024 |
Chief Executive Officer, Director |
NGNE |
Neurogene Inc. |
Jun 14, 2024 |
1 |
$0 |
4 |
Jun 17, 2024 |
Director |
ETNB |
89bio, Inc. |
Apr 1, 2024 |
3 |
-$527K |
4 |
Apr 3, 2024 |
Chief Executive Officer, Director |
ETNB |
89bio, Inc. |
Feb 26, 2024 |
1 |
-$48.2K |
4 |
Feb 28, 2024 |
Chief Executive Officer, Director |
ETNB |
89bio, Inc. |
Feb 17, 2024 |
1 |
-$44.8K |
4 |
Feb 23, 2024 |
Chief Executive Officer, Director |
ETNB |
89bio, Inc. |
Feb 9, 2024 |
1 |
-$107K |
4 |
Feb 13, 2024 |
Chief Executive Officer, Director |
ETNB |
89bio, Inc. |
Feb 1, 2024 |
3 |
-$49.7K |
4 |
Feb 5, 2024 |
Chief Executive Officer, Director |
NGNE |
Neurogene Inc. |
Jan 16, 2024 |
1 |
$0 |
4 |
Jan 18, 2024 |
Director |
ETNB |
89bio, Inc. |
Jan 5, 2024 |
2 |
-$317K |
4 |
Jan 8, 2024 |
Chief Executive Officer, Director |
ETNB |
89bio, Inc. |
Dec 29, 2023 |
3 |
-$464K |
4 |
Jan 3, 2024 |
Chief Executive Officer, Director |
ETNB |
89bio, Inc. |
Aug 17, 2023 |
1 |
-$69.6K |
4 |
Aug 21, 2023 |
Chief Executive Officer, Director |
ETNB |
89bio, Inc. |
Jun 30, 2023 |
2 |
-$313K |
4 |
Jul 5, 2023 |
Chief Executive Officer, Director |
NLTX |
Neoleukin Therapeutics, Inc. |
Jun 8, 2023 |
1 |
$0 |
4 |
Jun 9, 2023 |
Director |
ETNB |
89bio, Inc. |
Jun 5, 2023 |
3 |
-$271K |
4 |
Jun 7, 2023 |
Chief Executive Officer, Director |
ETNB |
89bio, Inc. |
Mar 31, 2023 |
2 |
-$235K |
4 |
Apr 4, 2023 |
Chief Executive Officer, Director |
ETNB |
89bio, Inc. |
Mar 23, 2023 |
1 |
-$240K |
4 |
Mar 27, 2023 |
Chief Executive Officer, Director |
ETNB |
89bio, Inc. |
Feb 17, 2023 |
1 |
-$87.7K |
4 |
Feb 22, 2023 |
Chief Executive Officer, Director |
ETNB |
89bio, Inc. |
Feb 9, 2023 |
2 |
$0 |
4 |
Feb 13, 2023 |
Chief Executive Officer, Director |
ETNB |
89bio, Inc. |
Feb 5, 2023 |
1 |
-$54K |
4 |
Feb 7, 2023 |
Chief Executive Officer, Director |
ETNB |
89bio, Inc. |
Sep 28, 2022 |
2 |
-$66.4K |
4 |
Sep 30, 2022 |
Chief Executive Officer, Director |
ETNB |
89bio, Inc. |
Sep 8, 2022 |
2 |
$193K |
4 |
Sep 9, 2022 |
Chief Executive Officer, Director |
NLTX |
Neoleukin Therapeutics, Inc. |
May 12, 2022 |
1 |
$0 |
4 |
May 16, 2022 |
Director |
NLTX |
Neoleukin Therapeutics, Inc. |
Mar 2, 2022 |
1 |
$0 |
4 |
Mar 4, 2022 |
Director |
NLTX |
Neoleukin Therapeutics, Inc. |
Mar 2, 2022 |
0 |
$0 |
3 |
Mar 4, 2022 |
Director |
ETNB |
89bio, Inc. |
Feb 17, 2022 |
2 |
$0 |
4 |
Feb 22, 2022 |
Chief Executive Officer, Director |
ETNB |
89bio, Inc. |
Feb 5, 2022 |
1 |
-$21.4K |
4 |
Apr 13, 2022 |
Chief Executive Officer, Director |
ETNB |
89bio, Inc. |
Jan 27, 2022 |
2 |
$52.9K |
4 |
Jan 31, 2022 |
Chief Executive Officer, Director |
ETNB |
89bio, Inc. |
Jul 7, 2021 |
2 |
$118K |
4 |
Jul 8, 2021 |
Chief Executive Officer, Director |